It’s common for men who have received an abnormal prostate cancer screening—typically discovered through a prostate-specific antigen blood test or digital rectal exam—to be referred to a urologist for further testing. The urologist will conduct a prostate biopsy to determine if cancer cells are present. This biopsy entails:
- Inserting a thin, hollow needle through the rectum or between the scrotum and anus
- Pushing the needle into the prostate to collect a small cylinder of prostate tissue
- Repeating this process several times to obtain as many samples as needed
The biopsy shouldn’t take longer than 10 minutes and will be conducted right in the urologist’s office. Within a few days, the urologist should have the results. If the biopsy is positive for cancer cells, the urologist will then discuss staging, treatment options and further steps with the patient. At this point, many patients will be referred to a medical oncologist—often one who specializes in urologic cancers—for cancer treatment.
Moffitt Cancer Center’s approach to prostate cancer treatment
At Moffitt Cancer Center, we take a multispecialty approach to prostate cancer treatment. In our Genitourinary Oncology Program, our seasoned team of highly specialized medical professionals provides individualized care for our patients. This team focuses solely on prostate cancer and similar genitourinary cancers, delivering a unique level of care to our patients.
In one convenient location, Moffitt provides a wide range of treatment options for prostate cancer, including surgery, radiation therapy, chemotherapy, biological therapy and clinical trials. Plus, we offer supportive care services to help patients and their families through the emotional journey of cancer treatment. With such expansive options for our patients, we’ve proudly been designated at a Comprehensive Cancer Center by the National Cancer Institute.